109 related articles for article (PubMed ID: 8606531)
1. Factors associated with hyperdynamic or hypodynamic circulation and role of platelet-activating factor in hemodynamic alterations in bacterial peritonitis in conscious rats.
Novo C; Ais G; López-Farré A; Romeo JM; Pérez-Barriocanal F; López-Novoa JM
J Cardiovasc Pharmacol; 1995 Dec; 26(6):937-42. PubMed ID: 8606531
[TBL] [Abstract][Full Text] [Related]
2. Systemic and regional hemodynamic changes during endotoxin or platelet activating factor (PAF)-induced shock in rats.
Mulder MF; van Lambalgen AA; van Kraats AA; Scheffer PG; Bouman AA; van den Bos GC; Thijs LG
Circ Shock; 1993 Dec; 41(4):221-9. PubMed ID: 8143350
[TBL] [Abstract][Full Text] [Related]
3. Role of platelet-activating factor in leukocyte-independent plasma extravasation and mast cell activation during endotoxemia.
Walther A; Yilmaz N; Schmidt W; Bach A; Gebhard MM; Martin E; Schmidt H
J Surg Res; 2000 Oct; 93(2):265-71. PubMed ID: 11027469
[TBL] [Abstract][Full Text] [Related]
4. Platelet activating factor is one of the mediators involved in endotoxic shock in pigs.
Mózes T; Heiligers JP; Tak CJ; Zijlstra FJ; Ben-Efraim S; Saxena PR; Bonta IL
J Lipid Mediat; 1991 Nov; 4(3):309-25. PubMed ID: 1764577
[TBL] [Abstract][Full Text] [Related]
5. A PAF receptor antagonist, BN 52021, attenuates thromboxane release and improves survival in lethal canine endotoxemia.
Moore JM; Earnest MA; DiSimone AG; Abumrad NN; Fletcher JR
Circ Shock; 1991 Sep; 35(1):53-9. PubMed ID: 1660355
[TBL] [Abstract][Full Text] [Related]
6. Role of free radicals and platelet-activating factor in the genesis of intestinal motor disturbances induced by Escherichia coli endotoxins in rats.
Pons L; Droy-Lefaix MT; Braquet P; Bueno L
Gastroenterology; 1991 Apr; 100(4):946-53. PubMed ID: 1672116
[TBL] [Abstract][Full Text] [Related]
7. Effects of the platelet-activating factor antagonist BN 52021 on the hemodynamics of rats with experimental cirrhosis of the liver.
Villamediana LM; Sanz E; Fernandez-Gallardo S; Caramelo C; Sanchez Crespo M; Braquet P; Lopez-Novoa JM
Life Sci; 1986 Jul; 39(3):201-5. PubMed ID: 3755490
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
[TBL] [Abstract][Full Text] [Related]
9. Effects of PAF and BN 52021 on cardiac function and regional blood flow in conscious rats.
Sirén AL; Feuerstein G
Am J Physiol; 1989 Jul; 257(1 Pt 2):H25-32. PubMed ID: 2546449
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of endotoxin and platelet activating factor in cirrhotic rats.
Kleber G; Braillon A; Gaudin C; Champigneulle B; Cailmail S; Lebrec D
Gastroenterology; 1992 Jul; 103(1):282-8. PubMed ID: 1612334
[TBL] [Abstract][Full Text] [Related]
11. Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia.
Fletcher JR; DiSimone AG; Earnest MA
Ann Surg; 1990 Mar; 211(3):312-6. PubMed ID: 2178565
[TBL] [Abstract][Full Text] [Related]
12. Involvement of platelet-activating factor (PAF) in endotoxin-induced intestinal motor disturbances in rats.
Pons L; Droy-Lefaix MT; Braquet P; Buéno L
Life Sci; 1989; 45(6):533-41. PubMed ID: 2570338
[TBL] [Abstract][Full Text] [Related]
13. Free radicals scavengers attenuate platelet-activating factor (PAF)- and endotoxin-induced intestinal myoelectric disturbances in rats.
Pons L; Droy-Lefaix MT; Braquet P; Buéno L
Free Radic Res Commun; 1991; 12-13 Pt 2():629-32. PubMed ID: 2060836
[TBL] [Abstract][Full Text] [Related]
14. Role of platelet-activating factor in hepatic responses after bile duct ligation in rats.
Zhou W; Chao W; Levine BA; Olson MS
Am J Physiol; 1992 Nov; 263(5 Pt 1):G587-92. PubMed ID: 1443133
[TBL] [Abstract][Full Text] [Related]
15. Role of platelet-activating factor in hemodynamic derangements in an acute rodent pancreatic model.
Ais G; López-Farre A; Gomez-Garre DN; Novo C; Romeo JM; Braquet P; López-Novoa JM
Gastroenterology; 1992 Jan; 102(1):181-7. PubMed ID: 1727752
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of endotoxin-induced increase in glucose metabolism by platelet-activating factor antagonist.
Lang CH; Dobrescu C; Hargrove DM; Bagby GJ; Spitzer JJ
Circ Shock; 1987; 23(3):179-88. PubMed ID: 3427772
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of the PAF-antagonist BN 52021 on several models of gastro-intestinal mucosal damage in rats.
Etienne A; Thonier F; Braquet P
Int J Tissue React; 1989; 11(2):59-64. PubMed ID: 2693389
[TBL] [Abstract][Full Text] [Related]
18. Contribution of platelet activating factor to hemodynamic and sympathetic responses to bacterial endotoxin in conscious rats.
Qi M; Jones SB
Circ Shock; 1990 Oct; 32(2):153-63. PubMed ID: 2253318
[TBL] [Abstract][Full Text] [Related]
19. Role of platelet activating factor in endotoxemic acute renal failure in the male rat.
Tolins JP; Vercellotti GM; Wilkowske M; Ha B; Jacob HS; Raij L
J Lab Clin Med; 1989 Mar; 113(3):316-24. PubMed ID: 2538527
[TBL] [Abstract][Full Text] [Related]
20. Myoelectric intestinal disturbances in Escherichia coli endotoxic shock in rats. Involvement of platelet-activating factor.
Pons L; Droy-Lefaix MT; Braquet P; Buéno L
Lipids; 1991 Dec; 26(12):1359-61. PubMed ID: 1819734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
